Lidocaine hydrochloride
| Code | Size | Price |
|---|
| TAR-T1144-500mg | 500mg | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Lidocaine hydrochloride is a local anesthetic and cardiac depressant used as an antiarrhythmic agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
CAS:
73-78-9
Formula:
C14H23ClN2O
Molecular Weight:
270.8
Pathway:
NF-κb; MAPK; Apoptosis; Membrane transporter/Ion channel
Purity:
0.9983
SMILES:
Cl.CCN(CC)CC(=O)Nc1c(C)cccc1C
Target:
Apoptosis; ERK; NF-κB; MEK; Sodium Channel
References
1. Yu HZ, et al. Basic Clin Pharmacol Toxicol. 2014, 114(4):352-9.
2. Kurabe M, et al. Sci Rep. 2016, 6:26253.
3. Sakaguchi M, et al. Anesth Analg. 2006, 102(4):1103-7.
4. Huang Z, Wei P, Gan L, et al. Protective effects of different anti?inflammatory drugs on tracheal stenosis following injury and potential mechanisms[J]. Molecular Medicine Reports. 2021, 23(5): 1-11.